Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 12Gliosarcoma 9Central Nervous System Neoplasms 6Astrocytoma 6Brain Neoplasms 5Oligodendroglioma 4Glioma 4Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 2Ovarian Neoplasms 2Glioma, Subependymal 2Ependymoma 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sinonasal Squamous Cell Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Pinealoma 1Pheochromocytoma 1Peritoneal Neoplasms 1Pancreatic Intraductal Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Mesothelioma 1Meningioma 1Melanoma 1

Interventions

Surgical Procedures, Operative 1Fluorouracil 1Drug Therapy 1Cisplatin 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Localized Resectable Adult Primary Liver Cancer × Surgical Procedures, Operative × Clear all
NCT00238160 2013-05-30

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

National Cancer Institute (NCI)

Phase 3 Withdrawn

Localized Resectable Adult Primary Liver Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡